Skip to content
10-K

Annual Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-23-012632

← back to feed
Filed
Apr 18, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Apr 17, 2023 42.96M sh
Stockholders Equity FY 2022 · Dec 31, 2022 $19.32K
Stockholders Equity FY 2022 · Dec 31, 2021 $38.17K
Stockholders Equity FY 2022 · Dec 31, 2020 $103.85K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$90.63K
Cash And Equivalents FY 2022 · Dec 31, 2021 $27.99K
Total Liabilities FY 2022 · Dec 31, 2021 $239
Total Assets FY 2022 · Dec 31, 2021 $38.41K
Sga Expense FY 2022 · Dec 31, 2021 $100.67K
Net Income FY 2022 · Dec 31, 2021 −$65.68K
Operating Income FY 2022 · Dec 31, 2021 −$65.68K
Revenue FY 2022 · Dec 31, 2021 $34.99K